Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) showed up in the 13F filings of 322 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 7,127,014 | 22.45% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 7,407,606 | 18.62% | $0.00 |
| ARK Investment Management LLC | 31 Dec, 2025 | 0 | 3,771,357 | 11.24% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | 1,508,219 | 1,174.51% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 7,064,963 | 38.67% | $0.00 |
| MIC Capital Management UK LLP | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -778,396 | -34.63% | $0.00 |
| BAILLIE GIFFORD & CO | 31 Dec, 2025 | 0 | -203,723 | -0.85% | $0.00 |
| Data Collective IV GP, LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 15,144 | 28.34% | $0.00 |
| SOFTBANK GROUP CORP. | 31 Dec, 2025 | 0 | -1,030,976 | -7.03% | $0.00 |
| Lingotto Investment Management LLP | 31 Dec, 2025 | 0 | -2,419,097 | -32.91% | $0.00 |
| Fund Advisors of America Inc/FL | 31 Dec, 2025 | 0 | 20,155 | 0.00% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 1,310,695 | 13.62% | $0.00 |
| DCVC Opportunity Fund II GP, LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Sumitomo Mitsui Trust Group, Inc. | 31 Dec, 2025 | 0 | -1,244,833 | -16.67% | $0.00 |
| Amova Asset Management Americas, Inc. | 31 Dec, 2025 | 0 | -1,244,833 | -16.67% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | -61,756 | -1.65% | $0.00 |
| NORGES BANK | 31 Dec, 2025 | 0 | 5,739,064 | 0.00% | $0.00 |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 31 Dec, 2025 | 0 | 629,123 | 35.44% | $0.00 |